283 related articles for article (PubMed ID: 22520130)
1. Workshop on intussusception in African countries--meeting report.
Steele AD; Patel M; Cunliffe NA; Bresee JS; Borgstein E; Parashar UD
Vaccine; 2012 Apr; 30 Suppl 1():A185-9. PubMed ID: 22520130
[TBL] [Abstract][Full Text] [Related]
2. Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.
Lloyd-Johnsen C; Justice F; Donath S; Bines JE
Vaccine; 2012 Apr; 30 Suppl 1():A190-5. PubMed ID: 22520131
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of using regional sentinel surveillance to monitor the rotavirus vaccine impact, effectiveness and intussusception incidence in the African Region.
Mandomando I; Weldegebriel G; de Deus N; Mwenda JM
Vaccine; 2017 Mar; 35(13):1663-1667. PubMed ID: 28242070
[TBL] [Abstract][Full Text] [Related]
4. Research priorities regarding rotavirus vaccine and intussusception: a meeting summary.
Tate JE; Steele AD; Bines JE; Zuber PL; Parashar UD
Vaccine; 2012 Apr; 30 Suppl 1():A179-84. PubMed ID: 22520129
[TBL] [Abstract][Full Text] [Related]
5. Rotavirus vaccines: targeting the developing world.
Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
[TBL] [Abstract][Full Text] [Related]
6. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
[TBL] [Abstract][Full Text] [Related]
7. Intussusception and rotavirus vaccination: a review of the available evidence.
Patel MM; Haber P; Baggs J; Zuber P; Bines JE; Parashar UD
Expert Rev Vaccines; 2009 Nov; 8(11):1555-64. PubMed ID: 19863248
[TBL] [Abstract][Full Text] [Related]
8. Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries.
Yen C; Healy K; Tate JE; Parashar UD; Bines J; Neuzil K; Santosham M; Steele AD
Hum Vaccin Immunother; 2016 Oct; 12(10):2580-2589. PubMed ID: 27322835
[TBL] [Abstract][Full Text] [Related]
9. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
[TBL] [Abstract][Full Text] [Related]
10. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.
Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437
[TBL] [Abstract][Full Text] [Related]
11. Preparing for the scale-up of rotavirus vaccine introduction in Africa: establishing surveillance platforms to monitor disease burden and vaccine impact.
Mwenda JM; Tate JE; Steele AD; Parashar UD
Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S1-5. PubMed ID: 24343605
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus vaccines and intussusception risk.
Bines JE
Curr Opin Gastroenterol; 2005 Jan; 21(1):20-5. PubMed ID: 15687880
[TBL] [Abstract][Full Text] [Related]
13. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
Bines JE; Patel M; Parashar U
J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus immunisation in Africa: a perspective re-visited.
Steele D
Afr J Health Sci; 2002; 9(3-4):113-6. PubMed ID: 17298153
[No Abstract] [Full Text] [Related]
15. Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2 years of age in four Asian countries.
Burnett E; Van Trang N; Rayamajhi A; Yousafzai MT; Satter SM; Anh DD; Thapa A; Qazi SH; Heffelfinger JD; Hung PH; Rayamajhi AK; Saddal N; Flora MS; Canh TM; Ali SA; Gurley ES; Tate JE; Yen C; Parashar UD
Vaccine; 2018 Nov; 36(50):7593-7598. PubMed ID: 30414781
[TBL] [Abstract][Full Text] [Related]
16. Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012).
Costantino C; Restivo V; Cuccia M; Furnari R; Amodio E; Vitale F
Ital J Pediatr; 2015 Aug; 41():52. PubMed ID: 26232152
[TBL] [Abstract][Full Text] [Related]
17. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
[TBL] [Abstract][Full Text] [Related]
18. Intussusception incidence rates in 9 Zambian hospitals, 2007-2011: prerotavirus vaccine introduction.
Mpabalwani EM; Chitambala P; Chibumbya JN; Matapo B; Mutambo H; Mwenda JM; Babaniyi O; Munkonge L
Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S94-8. PubMed ID: 24343623
[TBL] [Abstract][Full Text] [Related]
19. Intussusception, infection, and immunization: summary of a workshop on rotavirus.
Kombo LA; Gerber MA; Pickering LK; Atreya CD; Breiman RF
Pediatrics; 2001 Aug; 108(2):E37. PubMed ID: 11483847
[TBL] [Abstract][Full Text] [Related]
20. Implementation of the World Health Organization recommendation on the use of rotavirus vaccine without age restriction by African countries.
Mandomando I; Mumba M; Nsiari-Muzeyi Biey J; Kipese Paluku G; Weldegebriel G; Mwenda JM
Vaccine; 2021 May; 39(23):3111-3119. PubMed ID: 33958225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
